Ecmo Therapy With Impella Devices

ECpella

 

Hemodynamic Effects of ECpella with Impella 5.5® with SmartAssist® Heart Pumps

Learn more about the hemodynamic effects of Impella 5.5 with SmartAssist heart pumps.

About Impella 5.5 with SmartAssist

Benefits of ECpella - Therapy Options for Cardiogenic Shock Patients

Cardiogenic shock patients need advanced therapies that provide oxygenation and full cardiac support. Learn more about the benefits of the ECpella therapy.

Improved heart function

The combination of Impella heart pumps and ECMO technology helps support the heart and improve its function, leading to better blood flow and oxygenation.

Increased survival rates

Studies have shown that patients who receive ECpella therapy have higher survival rates compared to those who receive other forms of treatment.1

 

Early Left Ventricular Unloading Improves Survival in Patients in Cardiogenic Shock

Supported by Extracorporeal Membrane Oxygenation (ECMO)

New research shows that early left ventricular unloading with Impella heart pumps improves survival in patients with cardiogenic shock supported by extracorporeal membrane oxygenation (ECMO) - learn more in the interview with Dr. Benedikt Schrage.

Watch Interview

New Therapeutic Concepts of Combining ECLS With Impella Heart Pumps in Cardiogenic Shock

Dr. Armin Klesius interviews Prof. Evgenij Potapov on new therapeutic concepts in the field of ECpella therapy.

Access Interview

ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock

Jan Belohlavek, MD, PhD, discusses results from the ECMO-CS trial that he and his colleagues recently published in Circulation.

Access Interview

ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso, and Alan Gass

In this Q&A session from the Extracorporeal Life Support Organization (ELSO) meeting in 2022 the attendees discuss the importance of LV unloading for heart recovery and other aspects of managing ECpella patients.

Access Discussion

85% Survival with ECpella Approach Using the Impella 5.5® with SmartAssist® Heart Pump

Alan Gass, MD, discusses data he has published on the use of Impella 5.5® with SmartAssist® heart pump in patients with SCAI Stages D and E cardiogenic shock.

Access Presentation
 

Improving Survival in Cardiogenic Shock —

A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support

In this paper, Sascha Ott, Daniel Lewin, Gaik Nersesian, et al. describe a standard operating procedure (SOP) they developed for determining the temporary mechanical circulatory support (tMCS) strategy for patients in cardiogenic shock (CS).

Learn More

References

  1. Schrage et al :Timing of Active LV Unloading in VA-ECMO. JACC : HeartFailure V O L . -, NO. -, 2022.

Impella Platform

Impella CP® with SmartAssist® Heart Pump

Impella CP® with SmartAssist® Heart Pump

Percutaneous and axillary insertion, increased flow and intelligent patient management
Impella Connect®

Impella Connect®

Secure, cloud-based, remote monitoring of Impella® devices' status for better patient outcomes

NPS-3525

Are you a Health Care Professional?

Product information is intended to provide information on our products to medical professionals, not to the general public. Please confirm below.

No Yes

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].

The Protected PCI community
is now on HeartRecovery.com

Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
Explore Now